DIGITAL EDITION

ARCHIVES

Category: Letters to the Editor

Letter to the Editor: Role of Horse-assisted Therapy in the Rehabilitation Field: Past, Present, and Future Perspectives

Dear Editor: Central and peripheral nervous system lesions might induce paralysis, weakness, and/or loss of dexterity, which are the main target of rehabilitative interventions.1 In fact, a specific training with

Letter to the Editor: The Click-through Rate as a Measure of Dementia Health Promotion on YouTube

Dear Editor: Social media platforms are increasingly used to disseminate health promotion and patient education.1–5 Impressions click-through rate (CTR) is the number of clicks on a health promotion and/or patient

Letter to the Editor: Rethinking the robotic rehabilitation pathway for people with amyotrophic lateral sclerosis: a need for clinical trials

By Rocco Salvatore Calabrò, MD, PhD; Simona Portaro, MD, PhD; Alfredo Manuli, MSc; Antonino Leo, MSc; Antonino Naro, MD, PhD; and Alessia Bramanti, PhD IRCCS Centro Neurolesi “Bonino Pulejo”, Messina,

Letter to the Editor: When “Cure” becomes “Care” in Robotic Neurorehabilitation: The Critical Role of Nurses in a Novel Sicilian Multidisciplinary Approach

By Alfredo Manuli, MSc, and Rocco Salvatore Calabrò, MD, PhD Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this

Letter to the Editor: Looking Beyond the Obvious: Non-motor Parkinsonism

By Shivani Naik, MD; Murali Kolikonda, MD; Shanti Pittampalli, MD; Steven Lippmann, MD Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No

Letter to the Editor: Gait Rehabilitation following Neurological Disorders: Are Robotic Devices the Future?

By Rocco Salvatore Calabrò, MD, PhD; Alfredo Manuli, MSc; Antonino Leo, MSc; Margherita Russo, MD, PhD; Antonino Naro, MD, PhD; and Placido Bramanti, MD IRCCS Centro Neurolesi “Bonino-Pulej0,” Messina, Italy

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

By Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received

Letter to the Editor: Regarding Zika Microcephaly

By Beuy Joob, PhD, and Viroj Wiwanitkit, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the

Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?

By Benjamin K.P. Woo, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this

Letter to the Editor: Kratom and the Opioid Crisis

Innov Clin Neurosci. 2018;15(5–6):11–12 Dr. Bestha is with the Carolinas Healthcare System in Charlotte, North Carolina. Funding/financial disclosures. The author has no conflicts of interest relevant to the content of

Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a rapid progression, affecting motor neurons in the brain and spinal cord, ultimately leading to

Letter to the Editor: Olanzapine and Diabetic Ketoacidosis: What is the Underlying Mechanism?

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Recently, Iwaku et al1 reported a detailed case of olanzapine-related acute-onset Type 1 diabetes with ketoacidosis.1 They concluded that olanzapine sometimes can cause sudden

Letter to the Editor: Prolactin levels in Patients with Schizophrenia who were switched from daily to once-monthly Aripiprazole treatment

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Schizophrenia is a chronic and progressive psychiatric disorder requiring long-term treatment with antipsychotics. The use of long-acting injectable antipsychotics (LAI) has been shown to

Letter to the Editor: Pneumocephalus: Is the needle size significant?

Dear Editor: Pneumocephalus was first described in 1866, and the term was coined in 1914.[1] It is also known as a pneumatocele or intracerebral aerocele and may be classified as

Letter to the editor: Marijuana on the brain— a concern

Dear Editor: Marijuana is one of the most common illegal drugs consumed in the United States. Its use is growing in popularity, especially among young people, partly because of increasing

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

Dear Editor: Various surveillance systems are used to identify stroke and its sequela around the world, yet it is clear that stroke remains one of the top causes of mortality